View More Recent Stories

Feb 14, 2022 07:00AM Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Jan 25, 2022 07:30AM Biohaven's Nurtec® ODT Extends Partnership with Rick Ware Racing for 2022 NASCAR Cup Series and NTT INDYCAR Series
Jan 5, 2022 08:00AM Portage Biotech Announces Participation in January 2022 Investor Conferences
Jan 5, 2022 07:04AM Biohaven Pharma (BHVN), Pfizer (PFE) Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States
Jan 5, 2022 07:00AM Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States
Nov 23, 2021 08:00AM Portage Biotech Announces Financial Results and Provides Business Update for Second Quarter of 2022 Fiscal Year
Nov 22, 2021 04:53PM Portage Biotech to Present at the Piper Sandler 33rd Annual Healthcare Conference
Nov 15, 2021 08:00AM Portage Biotech Highlights Promising Efficacy and Survival Data Presented on Intensity Therapeutics’ INT230-6 (PORT-1) at November Scientific Conferences
Nov 10, 2021 08:00AM Portage Biotech Hosting Key Opinion Leader Webinar on How iNKT Agonists Could Improve Immuno-Oncology Treatment
Nov 9, 2021 07:46AM Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States
Nov 2, 2021 07:30AM Nine Line Apparel and Biohaven's Nurtec ODT Set to Honor World War II Veterans Ahead of 80th Anniversary at Phoenix Raceway
Sep 10, 2021 08:00AM Portage Biotech Announces Participation in September 2021 Investor Conferences
Aug 30, 2021 08:00AM Portage Biotech Announces Results for First Quarter of 2022 Fiscal Year
Aug 12, 2021 08:00AM Portage Biotech Issues Letter to Shareholders
Aug 5, 2021 08:00AM Portage Biotech Highlights First Patient Dosed in IMP-MEL Study of PORT-2 for the Treatment of Melanoma and Non-Small Cell Lung Cancer (NSCLC)
Jul 28, 2021 08:00AM Portage Biotech Announces Results for Fiscal Year Ended March 31, 2021
Jun 29, 2021 09:00AM Portage Biotech Added to Russell 2000(R) Index
Jun 24, 2021 09:04AM Portage Biotech (PRTG) Prices 1M Share Offering at $23/each
Jun 24, 2021 09:00AM Portage Biotech Inc. Announces Pricing of Public Offering of 1,000,000 Ordinary Shares
Jun 23, 2021 04:14PM Portage Biotech (PRTG) Announces Proposed Share Offering, Size not Disclosed
Jun 23, 2021 04:10PM Portage Biotech Inc. Announces Proposed Offering of Ordinary Shares
Jun 23, 2021 03:00AM Sosei Heptares Initiates Phase 1 Trial With Novel Small-Molecule CGRP Antagonist Under Collaboration With Biohaven
Jun 2, 2021 08:30AM Portage Biotech Highlights Safety and Survival Data from Intensity Therapeutics' IT-01 Study of INT230-6 (PORT-1) at ASCO 2021 Annual Meeting
May 14, 2021 07:30AM Biohaven's Nurtec® ODT Signs as Primary Partner with Rick Ware Racing for 2021 NTT INDYCAR Series Program
Apr 16, 2021 09:00AM Portage Biotech Announces Voluntary Delisting from the Canadian Securities Exchange
Apr 8, 2021 09:00AM Portage Biotech Highlights First Patient Dosed in PRECIOUS-01 Study of PORT-3 for the Treatment of NY-ESO-1 Positive Solid Tumors
Apr 6, 2021 07:30AM Rick Ware Racing, Biohaven's Nurtec ODT and Nine Line Apparel Honor Fallen Service Members
Mar 15, 2016 08:00AM Support.com Appoints Lowell Robinson and Elizabeth Fetter to Board of Directors
View More Recent Stories